Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03720899 · ClinicalTrials.gov registry record · Phase 2
Comparing NicoBloc to Nicotine Lozenges
A Phase 2 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 2
- Development phase
- 45
- Enrollment target
NCT03720899 is a Phase 2 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 45 participants.
The verdict
NCT03720899, a Phase 2 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 45 participants
- Enrollment target
Study Summary
To examine the feasibility, acceptability, and preliminary impact of using NicoBloc compared to nicotine lozenges
Interventions
- DRUG Nicotine Lozenge
- DRUG NicoBloc
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2019-03-21 |
| Est. Completion | 2021-03-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03720899
The ClinicalTrials.gov registry entry for NCT03720899 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nicotine Lozenge is the first listed.
NCT03720899 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03720899 about?
NCT03720899 is a clinical study titled "Comparing NicoBloc to Nicotine Lozenges". To examine the feasibility, acceptability, and preliminary impact of using NicoBloc compared to nicotine lozenges
What is the current status of trial NCT03720899?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 45 participants. The study started on 2019-03-21. Estimated completion is 2021-03-03.
What interventions are being tested in trial NCT03720899?
The interventions under investigation include: Nicotine Lozenge (DRUG), NicoBloc (DRUG).
Who is sponsoring clinical trial NCT03720899?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.